The role of urethral dilation in managing pediatric neurogenic bladder dysfunction
Tóm tắt
Urethral dilation is an effective method of treating children with neurogenic bladders who have poor bladder compliance, high leak point pressure, and are unresponsive to standard therapy with anticholinergic medications and clean intermittent catheterization. Urethral dilation can be successfully applied to boys and girls and has few side effects. There are no demonstrated long-term effects on continence. However, the use of urethral dilation has been limited by two factors: 1) general disregard given to urethral dilation when applied to children and adults with recurrent urinary tract infections and lower urinary tract symptoms, and 2) the general efficacy of conventional therapy that limits the number of children who may actually benefit from the procedure.
Tài liệu tham khảo
Lapides J, Diokno AC, Silber SJ, Lowe BS: Clean intermittent self-catheterization in the treatment of urinary tract disease. J Urol 1971, 107:458–461.
McGuire EJ, Woodside JR, Borden TA, Weiss RM: Prognostic value of urodynamic testing in myelodysplastic patients. J Urol 1981, 126:205–209.
McGuire EJ, Woodside JR, Borden TA: Upper urinary tract deterioration in patients with myelodysplasia and detrusor hypertonia: a followup study. J Urol 1983, 129:823–826.
Johnston JH, Kathel BL: The obstructed neurogenic bladder in the newborn. Br J Urol 1971, 43:206–210.
Shochat SJ, Perlmutter AD: Myelodysplasia with severe neonatal hydronephrosis: the value of urethral dilation. J Urol 1972, 107:146–148.
Wang SC, McGuire EJ, Bloom DA: Urethral dilation in the management of urological complications of myelodysplasia. J Urol 1989, 142:1054–1055.
Bloom DA, Knechtel JM, McGuire EJ: Urethral dilation improves bladder compliance in children with myelomeningocele and high leak point pressures. J Urol 1990, 144:430–433.
Miller DC, Bloom DA, McGuire EJ, Park JM: Temporary perineal urethrostomy for external sphincter dilation in a male patient with high risk myelomeningocele. J Urol 2003, 170:1606–1609.
Park JM, McGuire EJ, Koo HP, et al.: External urethral sphincter dilation for the management of high risk myelomeningocele: 15-year experience. J Urol 2001, 165:2383–2388.
Kiddoo DA, Canning DA, Snyder HM III, Carr MC: Urethral dilation as treatment for neurogenic bladder. J Urol 2006, 176:1831–1834.
Han K, Glazier DB, Cummings KB, Barone JG: Periurethral haematomas in a child following urethral dilation for dysfunctional voiding. Br J Urol 1998, 81:920–921.
Bowen D, Bloom DA, Wan J, Park JM: Does external urethral sphincter dilation compromise continence outcome in high-risk myelomeningocele patients? Presented at the 106th American Urology Association Annual Meeting. Orlando, FL; May 19, 2008.
Weld KJ, Graney MJ, Dmochowski RR: Differences in bladder compliance with time and associations of bladder management with compliance in spinal cord injured patients. J Urol 2000, 163:1228–1233.
Lyon RP: What does urethral dilation really do? Birth Defects 1977, 13:439–441.
Lyon RP, Marshall S: Urinary tract infections and difficult urination in girls: long-term followup. Trans Am Assoc Genitourin Surg 1970, 62:69–72.
Kendall AR, Karafin L: Urinary tract infections in children: fact and fantasy. J Urol 1972, 107:1068–1072.
Furlong JH Jr: Urethral size in female children with results of urethral dilation. Delaware Med J 1968, 50:337–339.
Wein AJ, Schoenberg HW: A review of 402 girls with recurrent urinary tract infection. J Urol 1972, 107:329–331.
Kaplan GW, Sammons TA, King LR: A blind comparison of dilation, urethrotomy and medication alone in the treatment of urinary tract infections in girls. J Urol 1973, 109:917–919.
Lemack GE, Foster B, Zimmern PE: Urethral dilation in women: a questionnaire-based analysis of practice patterns. Urology 1999, 54:37–43.
Metwalli AR, Cheng EY, Kropp BP, Pope JC IV: The practice of urethral dilation for voiding dysfunction among fellows of the Section of Urology of the American Academy of Pediatrics. J Urol 2002, 168:1764–1767.